Interstitial lung disease in rheumatoid arthritis: response to IL-6R blockade.

Mohr M, Jacobi AM

Research article (journal)

Details about the publication

JournalScandinavian Journal of Rheumatology (Scand J Rheumatol)
Volume40
Issue5
StatusPublished
Release year2011
Language in which the publication is writtenEnglish
KeywordsMethotrexate; Female; Antirheumatic Agents; Antibodies Monoclonal Humanized; Steroids; Peptides Cyclic; Dyspnea; Arthritis Rheumatoid; Isoxazoles; Middle Aged; Receptors Interleukin-6. Rheumatoid Factor; Humans; Bronchoalveolar Lavage Fluid; Lung Diseases Interstitial; Drug Therapy Combination; Methotrexate; Female; Antirheumatic Agents; Antibodies Monoclonal Humanized; Steroids; Peptides Cyclic; Dyspnea; Arthritis Rheumatoid; Isoxazoles; Middle Aged; Receptors Interleukin-6. Rheumatoid Factor; Humans; Bronchoalveolar Lavage Fluid; Lung Diseases Interstitial; Drug Therapy Combination

Authors from the University of Münster

Jacobi, Annett Marita
Medical Clinic of Internal Medicine D (Nephrology and Rheumatology) (Med D)